Histamine Screening in Seafood
From cold-chain control to receiving inspection
Preventive control begins with species identification, rapid chilling and documented handling.
Histamine control starts before the test
Certain histamine-forming fish, including tuna, mahi-mahi and mackerel, can accumulate histamine when bacterial activity progresses after harvest. Once formed, histamine is not reliably removed by freezing, cooking, smoking or canning. Effective control therefore begins with rapid chilling and documented time–temperature management.
FDA’s November 2024 Compliance Policy Guide identifies 35 mg/kg in one or more subsamples as evidence of significant decomposition or mishandling and 200 mg/kg as a level associated with potential human illness. These are U.S. enforcement-guidance criteria, not universal legal limits; destination-market and product requirements still apply.
Three evidence streams should be interpreted together
A shipment may arrive cold after an earlier temperature deviation. Normal appearance or odor does not establish that histamine is below a relevant threshold, while a result from one convenient sample may not represent an entire lot. Records, sensory findings and analytical results should therefore be assessed within the same documented receiving plan.
A practical receiving workflow
Five steps from receiving to lot disposition
1 Identify susceptible species.
Classify incoming fish by species, supplier history, intended processing and destination market. Define the sampling units and acceptance or escalation criteria before testing.
2 Review cold-chain evidence.
Check harvest and chilling records, transport data, receiving temperatures and storage history. Investigate missing records, unexplained excursions and inconsistencies.
3 Prepare a representative sample.
Follow the current Instructions for Use for homogenization, extraction, centrifugation and dilution. Method suitability can change with species, tissue composition and preparation.
4 Screen and interpret correctly.
Treat the result as qualitative screening evidence. The five-minute claim refers to strip readout after sample preparation, not the complete workflow.
5 Link findings to action.
A suspect or positive result should trigger the documented follow-up procedure, which may include holding the lot, testing additional units, quantitative confirmation and supplier review.
FSTest Histamine Rapid Test Strip
The FSTest Histamine Rapid Test Strip (Cat. No. 24111) is a competitive lateral-flow assay for qualitative screening in applicable marine fish, freshwater fish and processed fish products. It can support receiving inspection and routine verification when the matrix, sampling plan and intended decision are suitable.
The published 30 mg/kg screening level can support preliminary screening around a relevant decision point, but a qualitative visual result cannot establish an exact concentration. Where lot release or regulatory compliance depends on a numerical result, use an appropriate validated quantitative method and the applicable sampling criteria.
Screening supports preventive control
Histamine management is fundamentally a process-control issue. Rapid screening adds useful verification evidence, but it cannot compensate for inadequate chilling, incomplete records or an unrepresentative sampling plan. A defensible program combines species-specific hazard assessment, time–temperature controls, representative sampling, rapid screening and quantitative confirmation where required.
References
1. FDA. Final Compliance Policy Guide for Scombrotoxin Histamine Forming Fish and Fishery Products
2. FDA. Fish and Fishery Products Hazards and Controls Guidance
3. FDA. Scombrotoxin Poisoning and Decomposition
4. FSTest. Histamine Rapid Test Strip Cat. No. 24111
Log in 
